MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.
Clinical trial NCT01498952 · COMPLETED
Trial details
- NCT number
- NCT01498952
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-17
- Primary completion
- 2013-04-09
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.